- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01520129
Pilot Study of Interpersonal and Social Rhythm Therapy for Subthreshold Bipolar
January 28, 2016 updated by: Holly Swartz, University of Pittsburgh
The investigators propose to conduct a 20 week open pilot study of Interpersonal and Social Rhythm Therapy (IPSRT) to treat individuals (n=18) with subthreshold bipolar (BP) who are currently depressed.
The investigators will conduct a preliminary evaluation of sleep-wake and social rhythm patterns in study participants using questionnaires and actigraphy.
Primary aims of this study are to evaluate feasibility of this treatment and assessment approach.
Exploratory aims are to examine 1) sleep-wake and social rhythm patterns in subthreshold BP, 2) impact of IPSRT on symptoms and functioning over time and 3) relationship between sleep-wake and social rhythm patterns and treatment outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Subthreshold bipolar disorder (BP) is a common, understudied, illness associated with high levels of impairment.
"Subthreshold" BP refers to individuals who have episodes of both depression and hypomania, but the episodes of hypomania do not last long enough or are characterized by too few symptoms to meet conventional criteria for "threshold" hypomania.
Compared to individuals with episodes of depression only (major depressive disorder or MDD), individuals with subthreshold BP have higher rates of suicide, earlier onset of illness, more episodes of depression, and more co-occurring psychiatric disorders.
Despite the severity of the disorder, virtually nothing is known about how to treat this illness.
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Depression and Manic Depression Prevention Program
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults age 18 - 65
- Meets criteria for bipolar disorder NOS, currently in an episode of major depression, as defined by the DSM-IV (American Psychiatric Association, 1994) and documented by the use of the Structured Clinical Interview for Axis I DSM-IV Disorders (SCID-I), and by a rating of >15 on the 25-item Hamilton Rating Scale for Depression (HRSD-25). We will limit inclusion specifically to those individuals who have histories of 1) at least one short (2-3 day) hypomanic episode OR 2) at least one subthreshold hypomanic episode (at least 4 consecutive days of elevated mood and 2 of the other symptoms of hypomania or irritable mood with 3 of the other symptoms of hypomania). NOTE: Like the National Comorbidity Survey Replication, individuals whose hypomania occurred while on antidepressant medication will not be excluded from the trial (Merikangas, personal communication, 2011).
- Ability and willingness to give informed, written consent.
- Subjects may participate in this study if they are currently taking psychotropic medications at time of informed consent. They will start study interventions if they still meet eligibility criteria after a one week wash-out period.
- Ability and willingness to participate in study procedures
Exclusion Criteria:
- Severe or poorly controlled concurrent medical disorders that may cause confounding depressive symptoms (i.e., untreated hypothyroidism or lupus) or require medication(s) that could cause depressive symptoms (i.e., high doses of beta blockers or alpha interferon)
- Meets criteria for one of the following concurrent DSM-IV psychiatric disorders: any psychotic or organic mental disorder, bipolar I disorder, bipolar II disorder, current alcohol or drug dependence, primary obsessive compulsive disorder or primary eating disorders. (primary refers to the diagnosis associated with the most functional impairment); borderline personality disorder; antisocial personality disorder
- Acute suicidal or homicidal ideation or requiring psychiatric hospitalization. Subjects who require inpatient treatment will be excluded (or discontinued) from the study and referred to one of WPIC's inpatient mood disorder units, or, if preferred, to an inpatient facility nearer to the patient's home
- Severe cognitive deficits that would preclude treatment with psychotherapy and/or prevent completion of study questionnaires
- Non-fluent in English. Subjects must be able to speak and understand English because one of the study interventions, IPSRT, is an experimental talk-therapy. The DMDPP does not have multilingual therapists.
- Current participation in another form of individual psychotherapy. Concurrent participation in couples therapy, peer support groups (such as Alcoholics Anonymous), or family therapy will be permitted
- Prior lack of response to a trial of at least 12 weeks of IPSRT conducted by a qualified IPSRT therapist
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Interpersonal and social rhythm therapy
IPSRT Subjects will receive weekly 45 minute sessions of IPSRT for 20 weeks.
IPSRT sessions focus on reducing symptoms by teaching patients to: a) increase regularity of social rhythms and regulate sleep-wake cycles; b) resolve interpersonal problems that contribute to mood symptoms (role dispute, role transition, grief, or interpersonal deficits); and c) recognize and accept the symptoms of subthreshold BP disorder (psychoeducation).
Although we train therapists in techniques that are specific to each component, in practice, these strategies are administered flexibly and fluidly, without distinct boundaries between modalities.
During the course of a session, therapists move seamlessly among the techniques, according to patients' needs.
|
IPSRT Subjects will receive weekly 45 minute sessions of IPSRT for 20 weeks.
IPSRT sessions focus on reducing symptoms by teaching patients to: a) increase regularity of social rhythms and regulate sleep-wake cycles; b) resolve interpersonal problems that contribute to mood symptoms (role dispute, role transition, grief, or interpersonal deficits); and c) recognize and accept the symptoms of subthreshold BP disorder (psychoeducation).
Although we train therapists in techniques that are specific to each component, in practice, these strategies are administered flexibly and fluidly, without distinct boundaries between modalities.
During the course of a session, therapists move seamlessly among the techniques, according to patients' needs.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression severity
Time Frame: 20 weeks
|
The primary endpoint is depression severity at week 20, which will be measured via the Hamilton Rating Scale for Depression 25-item score (HRSD-25) and the Young Mania Rating Scale (YMRS).
|
20 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2012
Primary Completion (Actual)
October 1, 2014
Study Completion (Actual)
October 1, 2014
Study Registration Dates
First Submitted
January 24, 2012
First Submitted That Met QC Criteria
January 26, 2012
First Posted (Estimate)
January 27, 2012
Study Record Updates
Last Update Posted (Estimate)
January 29, 2016
Last Update Submitted That Met QC Criteria
January 28, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO11110666
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bipolar Disorder NOS
-
Stanford UniversityTerminatedBipolar Disorder, NOSUnited States
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompletedBipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOSUnited States
-
Delbert RobinsonNational Institute of Mental Health (NIMH); National Alliance for Research...CompletedSchizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Bipolar Disorder | Psychosis NOSUnited States
-
Mclean HospitalNational Institute of Mental Health (NIMH); Massachusetts General Hospital; Boston... and other collaboratorsRecruitingSchizophrenia | Schizoaffective Disorder | Bipolar Disorder | Psychosis | Psychosis Nos/OtherUnited States
-
University of MinnesotaUniversity of California, San FranciscoCompletedSchizophrenia | Schizoaffective Disorder | Psychosis | Psychosis NOS | Schizophreniform Disorders | Unspecified Psychosis | Bipolar Disorder With Psychotic Features | Depression Psychotic FeatureUnited States
-
University of ArizonaInstitute for Mental Health ResearchCompletedSchizophrenia | Schizoaffective Disorder | Major Depression With Psychotic Features | Bipolar Disorder With Psychotic Features | Psychotic Disorder Not Otherwise Specified (NOS) | Recent-Onset PsychosisUnited States
-
Universitätsklinikum Hamburg-EppendorfRecruitingSchizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Bipolar Disorder | Delusional Disorder | Psychotic Disorder NOS | Severe Major Depression With Psychotic FeaturesGermany
-
University of ArizonaCompletedSchizophrenia | Schizoaffective Disorder | Major Depression With Psychotic Features | Bipolar Disorder With Psychotic Features | Psychotic Disorder Not Otherwise Specified (NOS)United States
-
University of ArizonaTerminatedSchizophrenia | Schizoaffective Disorder | Major Depression With Psychotic Features | Psychosis Not Otherwise Specified (NOS) | Bipolar Disorder With Psychotic FeaturesUnited States
-
Nathan Kline Institute for Psychiatric ResearchStanley Medical Research InstituteCompletedSchizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Autism Spectrum Disorder | Bipolar I Disorder | Psychotic Disorder Not Otherwise Specified | Bipolar II | Bipolar NOS(Not Otherwise Specified)United States
Clinical Trials on Interpersonal and social rhythm therapy
-
Mayo ClinicCompletedBipolar Disorder, Depressed
-
University of PittsburghCompletedBorderline Personality Disorder | Bipolar I DisorderUnited States
-
Brown UniversityThe Miriam Hospital; Michigan State University; Women and Infants Hospital of... and other collaboratorsTerminated
-
University of PittsburghCompletedBipolar DisorderUnited States
-
University of WashingtonNational Institute of Mental Health (NIMH)CompletedBipolar DisorderUnited States
-
Central South UniversityCompleted
-
University of PittsburghCompletedBipolar Disorder | Early InterventionUnited States
-
Emory UniversityRecruitingDepression | Alcoholism | Drug AbuseUnited States
-
University of PittsburghRecruiting
-
University of ArizonaUnited States Department of Defense; Southern Arizona VA Health Care SystemCompletedDepression | Posttraumatic Stress Disorder | Insomnia DisorderUnited States